D.E. Shaw & Co’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Buy |
+51,074
| New | +$175K | ﹤0.01% | 2846 |
|
|
2024
Q4 | – | Sell |
-420,240
| Closed | -$1.09M | – | 2979 |
|
|
2024
Q3 | $1.09M | Sell |
420,240
-46,325
| -10% | -$120K | ﹤0.01% | 2135 |
|
|
2024
Q2 | $1.38M | Buy |
466,565
+13,330
| +3% | +$39.5K | ﹤0.01% | 2013 |
|
|
2024
Q1 | $2.05M | Buy |
453,235
+422,602
| +1,380% | +$1.91M | ﹤0.01% | 1760 |
|
|
2023
Q4 | $175K | Sell |
30,633
-404,720
| -93% | -$2.31M | ﹤0.01% | 2708 |
|
|
2023
Q3 | $2M | Sell |
435,353
-77,450
| -15% | -$356K | ﹤0.01% | 1697 |
|
|
2023
Q2 | $3.31M | Sell |
512,803
-955,593
| -65% | -$6.17M | ﹤0.01% | 1477 |
|
|
2023
Q1 | $11.1M | Sell |
1,468,396
-979,008
| -40% | -$7.38M | 0.01% | 873 |
|
|
2022
Q4 | $24.8M | Sell |
2,447,404
-327,955
| -12% | -$3.32M | 0.03% | 503 |
|
|
2022
Q3 | $27.4M | Buy |
2,775,359
+1,672,839
| +152% | +$16.5M | 0.03% | 438 |
|
|
2022
Q2 | $11.7M | Buy |
1,102,520
+1,073,423
| +3,689% | +$11.4M | 0.01% | 876 |
|
|
2022
Q1 | $284K | Sell |
29,097
-37,014
| -56% | -$361K | ﹤0.01% | 3468 |
|
|
2021
Q4 | $945K | Buy |
66,111
+40,418
| +157% | +$578K | ﹤0.01% | 2771 |
|
|
2021
Q3 | $515K | Buy |
+25,693
| New | +$515K | ﹤0.01% | 2828 |
|